Homology Medicines
Katherine Gall is an experienced scientist currently serving as an Associate Scientist at Flux Therapeutics since March 2024. Previously, Katherine held a Principal Research Associate position at Homology Medicines, Inc. from April 2018 to August 2023, where responsibilities included leading assay development for AAV gene editing and therapy, as well as executing in vitro experiments with proprietary AAV capsids. Prior to that, Katherine worked at the University of Massachusetts Medical School from December 2015 to April 2018 in several research associate roles, focusing on ALS-associated proteins and managing a mouse colony. Katherine's earlier experience includes roles as an undergraduate research assistant at Cornell University and Florida Gulf Coast University, focusing on neuronal activity and vaccine development for Dengue Virus, respectively. Katherine earned a Bachelor of Science in Biology with a concentration in Neurobiology and Behavior from Cornell University.